Peptide based vaccine design: Synthesis and immunological characterization of branched polypeptide conjugates comprising the 276–284 immunodominant epitope of HSV-1 glycoprotein D
✍ Scribed by Gábor Mező; Balázs Dalmadi; Ilona Mucsi; Szilvia Bősze; Éva Rajnavölgyi; Dr Ferenc Hudecz
- Book ID
- 105360184
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 152 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1075-2617
- DOI
- 10.1002/psc.373
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The importance of the length and conjugation site of a protective epitope peptide (^276^SALLEDPVG^284^) from glycoprotein D of herpes simplex virus in branched polypeptide conjugates has been investigated. A new set of peptides, with a single attachment site and truncated sequences, was prepared. The immunogenicity of conjugates and the specificity of antibody responses elicited were investigated in BALB/c, C57/Bl/6 and CBA mice. It was found that the covalent coupling of the peptide comprising the 276–284 sequence of gD through its Asp residue at position 281 did not influence the immunogenic properties of the epitope, while involvement of the side chain of Glu at position 280 almost completely abolished immunogenicity. These results clearly indicated that the conjugation site of the epitope peptide influenced the intensity and specificity of antibody responses. Comparison of the immunological properties of conjugates containing truncated gD peptides revealed the presence of two epitopes within the 276–284 region. One of the proposed epitopes is situated at the N‐terminal (276–281) region, while the other is located at the C‐terminal end of the sequence (279–284). Binding data demonstrated that some of the peptides comprising these epitopes induced gD‐specific responses in their conjugated form and also elicited an immune response that conferred protection against lethal HSV‐1 infection. The correlation of peptide‐ and gD‐specific antibody responses with the protective effect of the immune response is discussed. Copyright © 2002 European Peptide Society and John Wiley & Sons, Ltd.